Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Viavi Solutions Inc. entered into an underwriting agreement for a public stock offering of 11,111,111 common shares at $45.00 per share, with underwriters exercising a 30‑day option to buy an additional 1,666,666 shares in full. The company expects approximately $557.2 million in net proceeds, and currently plans to use this to repay $450 million outstanding under a 7‑year term loan facility entered in March 2025, with any remaining funds for working capital and general corporate purposes. Viavi, its executives and directors agreed to customary 60‑day lock‑up arrangements that limit additional share sales.
Viavi Solutions is offering 11,111,111 shares of common stock pursuant to this prospectus supplement. The offering price is $45.00 per share for total gross proceeds of $499,999,995, with underwriters’ discounts of $1.35 per share. We estimate net proceeds to us of approximately $484.4 million, which we currently intend to use to repay the $450 million aggregate principal amount of our Term Loan B. The underwriters have an option to purchase up to 1,666,666 additional shares within 30 days.
Shares outstanding were 233,907,870 as of April 25, 2026; the prospectus shows common stock to be outstanding immediately after this offering of 245,018,981 shares (or 246,685,647 shares if the underwriters’ option is exercised in full). The prospectus supplement also presents March 28, 2026 cash and capitalization as adjusted to reflect the offering and application of net proceeds.
Viavi Solutions Inc. is offering common stock with an aggregate public offering price of $500,000,000. This prospectus supplement is preliminary and subject to completion, dated May 19, 2026. The underwriters have a 30-day option to purchase additional shares with an aggregate public offering price of up to $75,000,000. The company states estimated net proceeds will be used to repay the $450 million aggregate principal amount of its 7-year Term Loan B entered into in October 2025; any excess will be used for working capital and general corporate purposes. Shares outstanding were 233,907,870 as of April 25, 2026. The offering assumes no exercise of the underwriters' option unless noted.
Viavi Solutions Inc. is offering common stock with an aggregate public offering price of $500,000,000. This prospectus supplement is preliminary and subject to completion, dated May 19, 2026. The underwriters have a 30-day option to purchase additional shares with an aggregate public offering price of up to $75,000,000. The company states estimated net proceeds will be used to repay the $450 million aggregate principal amount of its 7-year Term Loan B entered into in October 2025; any excess will be used for working capital and general corporate purposes. Shares outstanding were 233,907,870 as of April 25, 2026. The offering assumes no exercise of the underwriters' option unless noted.
Viavi Solutions Inc. reported board-level governance changes focused on committee leadership and composition. Effective May 12, 2026, independent director Joanne Solomon was appointed Chair of the Audit Committee, replacing Donald Colvin, who remains an independent director and Audit Committee member.
The Board states Mr. Colvin’s decision to step down as chair was not due to any disagreement regarding the company’s operations, policies, or practices, and that the move supports board refreshment and succession planning. Ms. Solomon has served on the Board and Audit Committee since February 2022 and is designated an “audit committee financial expert.”
On the same date, the Board appointed independent director Doug Gilstrap to the Corporate Development Committee. Mr. Gilstrap, who joined the Board in November 2022, also serves on the Compensation Committee. These changes adjust committee responsibilities while maintaining overall board continuity.
Viavi Solutions Inc. ownership disclosure: Capital World Investors files Amendment No. 1 to report beneficial ownership of 11,570,319 shares, representing 5.0% of 231,389,345 shares stated as outstanding. The filing shows sole voting and sole dispositive power over those shares. The filing is dated 03/31/2026 with a signature dated 05/13/2026.
VIAV filed a Form 144 reporting proposed sales of Common stock by Oleg Khaykin and related irrevocable trusts.
The excerpt lists multiple reported transactions: 123,333 shares on 05/07/2026 for $6,342,855.86; 104,552 shares on 05/05/2026 for $5,709,919.29; and additional trust sales on 05/06/2026, 05/05/2026, 02/10/2026, 02/09/2026 with amounts shown for each line item. The filing also references performance share awards dated 09/26/2023 and 03/01/2025.
VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported selling a total of 259,880 shares of Common Stock in open-market transactions. He sold 123,333 shares on May 7, 2026 at a price of $51.43 per share and 136,547 shares on May 8, 2026 at $51.82 per share.
Following these sales, Khaykin directly holds 1,188,798 shares of Viavi common stock. The filing notes that each day’s transaction was executed in multiple trades, with prices on May 7 ranging from $51.22 to $51.68 and on May 8 from $51.75 to $52.15, with reported prices reflecting weighted averages.
VIAV insiders reported planned sales via Form 144 totaling multiple blocks of common stock. The excerpt lists specific sales and proposed sales by Oleg Khaykin, Helen Khaykin, and related trusts with transaction dates in 2026 and earlier restricted/performance share grants dated 2018–2020.
VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported an open-market sale of 34,024 shares of common stock. The shares were sold on May 6, 2026 at a weighted average price of $54.07 per share, based on multiple trades between $54.00 and $54.12. After this transaction, Khaykin directly holds 1,448,678 shares of VIAVI common stock.
VIAVI Solutions Inc. submitted a Form 144 notice related to proposed sales of Common stock via Morgan Stanley Smith Barney LLC Executive Financial Services. The filing lists restricted shares and performance-share awards with grant dates 08/28/2018, 05/28/2020, and 09/25/2020, and reports multiple recent dispositions including 20,238 and 104,552 shares on 05/05/2026.